Search
.jpg-650.jpg)
Thermo Scientific™
B·R·A·H·M·S™ CgA II KRYPTOR™
Thermo Scientific B·R·A·H·M·S CgA II KRYPTOR is the first-FDA-cleared, automated immunofluorescent assay for determining CgA concentration in human serum.
Have Questions?
Modifier l'affichage
| Référence | Description | À utiliser avec (application) |
|---|---|---|
| 083992N | Contrôles pour B-R-A-H-M-S CgA II KRYPTOR (2 niveaux) | Contrôle de qualité du dosage B-R-A-H-M-S CgA II KRYPTOR |
| 839050N | Test d’immunofluorescence pour la détermination quantitative de la chromogranine A (CgA) soluble | Le test B·R·A·H·M·S CgA II KRYPTOR est indiqué comme aide à l’évaluation clinique pour le suivi et la surveillance des patients atteints de tumeurs neuroendocrines (TNE) et pour la surveillance thérapeutique des patients atteints de cancer de la prostate. Le test est également indiqué comme aide à l’évaluation clinique pour le diagnostic des patients suspectés de phéochromocytome. Veuillez consulter le mode d’emploi disponible dans votre pays. |
| 083991N | Étalonneur for B·R·A·H·M·S CgA II KRYPTOR | Réajuster la courbe standard mémorisée dans B-R-A-H-M-S KRYPTOR compact PLUS/KRYPTOR GOLD |
Référence 083992N
Prix (EUR)
-
Description:
Contrôles pour B-R-A-H-M-S CgA II KRYPTOR (2 niveaux)
À utiliser avec (application):
Contrôle de qualité du dosage B-R-A-H-M-S CgA II KRYPTOR
Thermo Scientific™ B·R·A·H·M·S™ CgA II KRYPTOR™ is an automated immunofluorescent assay using Time-Resolved amplified Cryptate Emission (TRACE™) technology to determine the concentration of Chromogranin A (CgA) in human serum. B·R·A·H·M·S CgA II KRYPTOR is indicated as an aid to be used in conjunction with clinical evaluation for follow-up and monitoring of patients with neuroendocrine tumors (NETs) and for therapy monitoring of patients with prostate cancer. The test is further indicated as an aid to be used in conjunction with clinical evaluation for the diagnosis of patients with suspected pheochromocytomas. Please consult the Instructions For Use (IFU) available in your country.
Intended Use for US only: B·R·A·H·M·S CgA II KRYPTOR is to be used in conjunction with other clinical methods as an aid in monitoring of disease progression during the course of disease and treatment in patients with gastroentero-pancreatic neuroendocrine tumors (GEP-NETs, grade 1 and grade 2).
- Chromogranin A is an acidic, hydrophilic protein of 49 kDa present in chromaffin granules of the neuroendocrine cells and is a member of the granin family.
- Neuroendocrine tumors (NETs) originate from neuroendocrine cells found in neuronal and endocrine tissues throughout the body.
- The most common sites of NETs are the lung, stomach, appendix, cecum, duodenum, pancreas, jejunum/ileum, colon and rectum.
- NETs arising from the gastrointestinal tract are collectively known as gastroentero-pancreatic neuroendocrine tumors.
- Follow up and monitoring investigations of NETs are based on tumor markers together with other diagnostic measures and clinical signs.
- Besides its use as immunohistological marker, CgA has been well recognized as a general broad-spectrum serum marker in GEP-NETs.
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
Spécifications
DescriptionContrôles pour B-R-A-H-M-S CgA II KRYPTOR (2 niveaux)
À utiliser avec (application)Contrôle de qualité du dosage B-R-A-H-M-S CgA II KRYPTOR
ComprendControls kit, 6 vials
Substances à analyser détectablesChromogranin A (CgA)
FormeLyophilized
Unit SizePack of 6
Contenu et stockage
Controls kit, 6 vials, 2-8°C